Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volmer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Archives of Gynecology and Obstetrics|April 21, 2026
The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort studyK Eissler, T Engler, D Dannehl, et al.
South Dakota Journal of Medicine|August 10, 2000
Epidemiology of diphtheria in South DakotaA Golaz, S Lance-Parker, T Welty, et al.
Journal of Personalized Medicine|March 25, 2022
Feasibility of Adjuvant Treatment with Abemaciclib-Real-World Data from a Large German Breast CenterDominik Dannehl, Lea L Volmer, Martin Weiss, et al.
Cancers|November 11, 2022
Recurrence Score<sup>®</sup> Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA TrialDominik Dannehl, Tobias Engler, Lea L Volmer, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
JMIR Research Protocols|June 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
ESMO Open|April 18, 2024
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysisD Dannehl, D Jakob, F Mergel, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Cardiovascular and Interventional Radiology|June 23, 2025
Prospective Registry Study on Thermal Liver Ablation of Primary and Secondary Liver Tumours Named the A-IMAGIO StudyA L van der Velden, C A M Verhagen, F Gholamiankhah, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Archives of Gynecology and Obstetrics|April 21, 2026
The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort studyK Eissler, T Engler, D Dannehl, et al.
South Dakota Journal of Medicine|August 10, 2000
Epidemiology of diphtheria in South DakotaA Golaz, S Lance-Parker, T Welty, et al.
Journal of Personalized Medicine|March 25, 2022
Feasibility of Adjuvant Treatment with Abemaciclib-Real-World Data from a Large German Breast CenterDominik Dannehl, Lea L Volmer, Martin Weiss, et al.
Cancers|November 11, 2022
Recurrence Score<sup>®</sup> Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA TrialDominik Dannehl, Tobias Engler, Lea L Volmer, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
JMIR Research Protocols|June 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
ESMO Open|April 18, 2024
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysisD Dannehl, D Jakob, F Mergel, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Cardiovascular and Interventional Radiology|June 23, 2025
Prospective Registry Study on Thermal Liver Ablation of Primary and Secondary Liver Tumours Named the A-IMAGIO StudyA L van der Velden, C A M Verhagen, F Gholamiankhah, et al.
Pageof 2